Trials / Recruiting
RecruitingNCT06117384
Systems Oncology Approach to Optimize Ovarian Cancer Treatment
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- University of Helsinki · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The overall aim is to identify effective therapeutic strategies to ovarian cancer (OC) using serial tumor, ascites and blood samples, and carry out state-of-the-art sequencing approaches, functional assays and associated bioinformatics to understand mechanisms behind chemoresistance in OC and identify new treatment options for OC patients. In this observational trial, we will systematically collect, analyze and interpret functional, molecular and clinical data from real-world ovarian cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Biomolecular profiling | Molecular and functional analysis of biospecimens, including tumor-normal Whole-exome sequencing, bulk and single-cell RNAsequencing, spatial proteomics, functional testing. |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
- First posted
- 2023-11-07
- Last updated
- 2023-11-07
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT06117384. Inclusion in this directory is not an endorsement.